Original Article
A Comparison of Two Antimicrobial-Impregnated Central Venous Catheters
N Engl J Med 1999; 340:1-8January 7, 1999
- Abstract
Background
The use of central venous catheters impregnated with either minocycline and rifampin or chlorhexidine and silver sulfadiazine reduces the rates of catheter colonization and catheter-related bloodstream infection as compared with the use of unimpregnated catheters. We compared the rates of catheter colonization and catheter-related bloodstream infection associated with these two kinds of antiinfective catheters.
Methods
We conducted a prospective, randomized clinical trial in 12 university-affiliated hospitals. High-risk adult patients in whom central venous catheters were expected to remain in place for three or more days were randomly assigned to undergo insertion of polyurethane, triple-lumen catheters impregnated with either minocycline and rifampin (on both the luminal and external surfaces) or chlorhexidine and silver sulfadiazine (on only the external surface). After their removal, the tips and subcutaneous segments of the catheters were cultured by both the roll-plate and the sonication methods. Peripheral-blood cultures were obtained if clinically indicated.
Results
Of 865 catheters inserted, 738 (85 percent) produced culture results that could be evaluated. The clinical characteristics of the patients and the risk factors for infection were similar in the two groups. Catheters impregnated with minocycline and rifampin were 1/3 as likely to be colonized as catheters impregnated with chlorhexidine and silver sulfadiazine (28 of 356 catheters [7.9 percent] vs. 87 of 382 [22.8 percent], P<0.001), and catheter-related bloodstream infection was 1/12 as likely in catheters impregnated with minocycline and rifampin (1 of 356 [0.3 percent], vs. 13 of 382 [3.4 percent] for those impregnated with chlorhexidine and silver sulfadiazine; P<0.002).
Conclusions
The use of central venous catheters impregnated with minocycline and rifampin is associated with a lower rate of infection than the use of catheters impregnated with chlorhexidine and silver sulfadiazine.
Media in This Article
Figure 2
Representative DNA-Fingerprint Patterns in Repetitive-Element Polymerase-Chain-Reaction Analysis of Isolates from Cultures of Catheter Segments, Peripheral Blood, and Skin from Seven Patients with Catheter-Related Bloodstream Infection.Figure 1
Kaplan–Meier Curves for Freedom from Bloodstream Infection with Catheters Impregnated with Either Minocycline and Rifampin or Chlorhexidine and Silver Sulfadiazine.Article Activity
- Article
Infection associated with the use of central venous catheters can result in serious medical complications and expensive care.1 In prospective, randomized clinical trials, the use of central venous catheters impregnated with either minocycline and rifampin2 or chlorhexidine and silver sulfadiazine3 was associated with reduced rates of catheter colonization and catheter-related bloodstream infection, as compared with unimpregnated catheters. In vitro studies4 and studies in animals5 have suggested that catheters impregnated with minocycline and rifampin can resist infection more effectively than catheters impregnated with chlorhexidine and silver sulfadiazine, but the clinical efficacy of these two types of antiinfective catheters has not been compared directly. We compared catheters impregnated with minocycline and rifampin with those impregnated with chlorhexidine and silver sulfadiazine in terms of the rates of colonization of catheters and bloodstream infection.
Methods
Patients
The trial was conducted between December 1995 and July 1997 in 12 university-affiliated hospitals. The study was approved by the appropriate institutional review boards. Hospitalized adults who were at high risk for catheter-related infection (such as patients in intensive care units or those who were immunocompromised) and were likely to require a central venous catheter for three or more days were eligible for the study. Pregnant women and patients with a history of allergy to any of the antimicrobial agents used for impregnating the catheters were excluded. All enrolled patients or their legal guardians gave informed consent.
Catheters
Patients were randomly assigned to undergo implantation of 7-French, 20-cm-long, noncuffed, triple-lumen polyurethane central venous catheters impregnated with either minocycline and rifampin (Cook Spectrum, Cook Critical Care, Bloomington, Ind.) or chlorhexidine and silver sulfadiazine (Arrowguard Blue, Arrow International, Reading, Pa.). Both types of catheter are available for clinical use; the retail prices of a catheter tray are $70 and $61, respectively. The catheters impregnated with minocycline and rifampin provided antimicrobial activity on both the external and the internal surfaces. Examination by high-performance liquid chromatography showed that these catheters contained higher amounts of minocycline and rifampin (11.08 and 10.50 mg per catheter, respectively) than those previously studied (2.79 and 0.28 mg per catheter, respectively).2,5 In contrast, only the external surface of catheters impregnated with chlorhexidine and silver sulfadiazine (0.75 and 0.70 mg per catheter, respectively) provided antimicrobial activity.3 All study catheters were sterilized with ethylene oxide before use.
Randomization
A special randomization scheme was used to help match the two study groups closely. Catheter trays wrapped in identical folders were randomly assigned in blinded fashion according to computer-generated identification numbers, in blocks of six (three from each group), so that the catheter trays would be removed from the box one at a time in the prescribed, random order from the top to the bottom. Blocks of six catheters were then shipped to the participating hospitals for assignment to specified patient-care units. In each case, the patients, nurses, physicians, and principal investigators who assessed the outcomes in each hospital were unaware of the type of catheter inserted.
Insertion and Maintenance of Catheters
Attending physicians, house staff, or supervised medical students inserted the catheters into the subclavian, jugular, or femoral vein using maximal sterile-barrier precautions. To avoid the potential confounding effect of the controversial practice of catheter exchange over a guide wire, we determined at the outset of the trial to study only catheters inserted through a new venipuncture. Randomly selected study catheters could be inserted subsequently at new sites in the same patient, so long as that patient had only one study catheter at a time. At the time of catheter insertion and at each dressing change, the insertion site was disinfected with 10 percent povidone–iodine. The dressing was changed and the insertion site was inspected three times a week. Coordinators at each study location evaluated patients daily until the catheter was removed. The decision to remove the catheter was made solely by the patient's physician, who kept the catheter in place until it was no longer needed or until an adverse event, such as catheter-related infection or catheter occlusion, necessitated its removal.
Cultures
Four-centimeter segments from the tips and subcutaneous sections of the aseptically removed catheters were cultured by the roll-plate method,6 then cultured by the sonication method.7 To help identify the sources of organisms that colonize catheters, swab cultures of surrounding skin were obtained at the times of catheter insertion and catheter removal in four participating hospitals. In patients in whom catheter-related infection was suspected on clinical grounds, one or more peripheral-blood samples for culture were collected before or immediately after catheter removal. Recovered organisms were identified by standard microbiologic methods.
Molecular Typing
Bacterial isolates from cultures of blood, catheters, and, when available, skin of patients in whom catheter-related bloodstream infection was diagnosed were typed by genomic fingerprinting with the use of the repetitive-element polymerase chain reaction.8 If the same bacterial species was isolated from different sites in a single patient, DNA-fingerprint patterns were compared for similarity by visual inspection of band patterns and by computer-assisted analysis (RFLPscan Plus, Scanalytics, Billerica, Mass.). Bacterial isolates were considered similar if fingerprint patterns differed by no more than one amplification band.
Antimicrobial Susceptibility
To help determine whether these antimicrobial-impregnated catheters increase the likelihood of the emergence of antibiotic resistance, we compared the minimal inhibitory concentrations and minimal bactericidal concentrations for bacteria isolated from the two kinds of catheters by a standard broth-microdilution assay.9
Definitions
We adopted the definitions of catheter colonization and infection proposed by the Centers for Disease Control and Prevention10,11 and used in previous clinical trials.2 Catheter colonization was defined as the growth of 15 or more colony-forming units in culture of catheter segments prepared by the roll-plate method or 1000 or more colony-forming units in cultures prepared by the sonication method from either the tip or a subcutaneous segment of the catheter. Catheter-related bloodstream infection was defined as the isolation of the same organism (i.e., the same species with identical antimicrobial susceptibility) from the colonized catheter and from peripheral blood in a patient with clinical manifestations of sepsis and no other apparent source of bloodstream infection.
Statistical Analysis
Before undertaking this study, we estimated the number of catheters that would be required for an adequate examination of the hypothesis that catheters impregnated with minocycline and rifampin are significantly less likely to be colonized than catheters impregnated with chlorhexidine and silver sulfadiazine. On the basis of previous reports, we estimated that 7 percent of catheters impregnated with minocycline and rifampin2 and 13.6 percent of catheters impregnated with chlorhexidine and silver sulfadiazine3 would be colonized. Randomly assigning approximately 362 catheters that could be evaluated to each group would have allowed us to detect with 80 percent power a significant difference in the rates of colonization between the two types of catheters at a two-tailed significance level of 5 percent.
The significance of the differences between the two study groups was determined with use of Student's t-test or the Wilcoxon rank-sum test for continuous variables and Fisher's exact test or the chi-square test for categorical variables. All P values were based on two-tailed tests of significance. The proportions of catheters that were free of colonization and not associated with bloodstream infection as a function of the length of time they had been in place were compared between the groups with use of a log-rank test on Kaplan–Meier estimates. A multivariate logistic-regression model was used to estimate the simultaneous effects of multiple variables on the incidence of catheter colonization and catheter-related bloodstream infection. To avoid rejecting variables that might have influenced the risk of catheter colonization or catheter-related bloodstream infection, variables that were significant at a P value of 0.25 or less in the univariate analysis were entered in stepwise fashion into logistic-regression analyses and tested for an independent effect. The limit for entering or removing variables in the logistic-regression models was a P value of 0.05 or less. All computations were performed with SAS/STAT software.12 An independent monitoring board composed of experts on infectious diseases reviewed and helped interpret the findings of the study. An interim analysis of the data was not performed.
Results
Characteristics of Patients and Catheters
A total of 865 study catheters (414 impregnated with minocycline and rifampin and 451 impregnated with chlorhexidine and silver sulfadiazine) were inserted into 817 patients. Complete data could be evaluated for 738 catheters (85 percent): 356 impregnated with minocycline and rifampin and 382 impregnated with chlorhexidine and silver sulfadiazine, inserted in 698 patients. The remaining 127 catheters (58 impregnated with minocycline and rifampin and 69 impregnated with chlorhexidine and silver sulfadiazine, with similar patient and catheter characteristics) were not cultured (84 were removed without notification of study coordinators, 19 were grossly contaminated during removal, and 24 were not available for other reasons) and therefore were excluded from further analysis. The two groups of catheters that could be evaluated were similar with respect to characteristics of patients and catheters (Table 1Table 1
Characteristics of the Patients and Antimicrobial-Impregnated Catheters.).Colonization of Catheters
Eighty-seven of 382 catheters impregnated with chlorhexidine and silver sulfadiazine (22.8 percent) and 28 of 356 catheters impregnated with minocycline and rifampin (7.9 percent) were colonized according to at least one method of assessment (relative risk, 2.90; 95 percent confidence interval, 1.94 to 4.33; P<0.001). Catheters impregnated with minocycline and rifampin were less likely to be colonized than those impregnated with chlorhexidine and silver sulfadiazine, whether the catheter remained in place for seven days or less (13 of 217 catheters [6.0 percent] vs. 45 of 210 [21.4 percent], P<0.001) or for more than seven days (15 of 139 [10.8 percent] vs. 42 of 172 [24.4 percent], P<0.002). Analysis of the Kaplan–Meier estimates of the risk of catheter colonization according to the length of time the catheters were in place in each group showed that catheters impregnated with minocycline and rifampin were significantly less likely to be colonized (P<0.001 by the log-rank test). The overall beneficial effect of the use of catheters impregnated with minocycline and rifampin was seen in all hospitals that contributed more than 32 catheters that could be evaluated. Catheters impregnated with minocycline and rifampin were also significantly less likely to be colonized than catheters impregnated with chlorhexidine and silver sulfadiazine (P<0.001) according to each of the four combinations of catheter segment and culture method (tip–roll plate, tip–sonication, subcutaneous segment–roll plate, and subcutaneous segment–sonication) or any combination of these assessment methods.
Catheters impregnated with chlorhexidine and silver sulfadiazine were significantly more likely than those impregnated with minocycline and rifampin to be colonized with coagulase-negative staphylococci (18 percent vs. 4 percent; relative risk, 4.16; 95 percent confidence interval, 2.42 to 7.14; P<0.001), gram-positive bacilli (2 percent vs. 0.3 percent; relative risk, 7.46; 95 percent confidence interval, 0.94 to 58.8; P=0.04), or gram-negative bacilli (4 percent vs. 1 percent; relative risk, 3.96; 95 percent confidence interval, 1.35 to 11.63; P=0.007). However, the rates of colonization of catheters with Staphylococcus aureus (1 percent vs. 0), enterococci (2 percent vs. 2 percent), and yeast (2 percent vs. 3 percent) did not differ significantly between the two groups.
Factors that may have increased the likelihood of catheter colonization (detected by any of the assessment methods) in the univariate analysis (P≤0.25) were entered into a multivariate logistic-regression model, which identified the following predisposing factors as significant (P≤0.05): insertion of the catheter into the femoral or jugular vein (odds ratio as compared with other locations, 3.05; 95 percent confidence interval, 1.86 to 5.01; P<0.001), use of a catheter impregnated with chlorhexidine and silver sulfadiazine (odds ratio as compared with minocycline and rifampin, 2.80; 95 percent confidence interval, 1.68 to 4.66; P<0.001), hospitalization in the intensive care unit (odds ratio as compared with other wards, 2.60; 95 percent confidence interval, 1.47 to 4.62; P=0.001), male sex (odds ratio, 2.45; 95 percent confidence interval, 1.43 to 4.20; P=0.001), and mechanical ventilation (odds ratio, 1.97; 95 percent confidence interval, 1.14 to 3.41; P=0.01).
Catheter-Related Bloodstream Infection
In 14 cases, bloodstream infection was attributed to an indwelling study catheter. These catheters had been in place for a median of 11 days. Thirteen cases of catheter-related bloodstream infection occurred among the catheters impregnated with chlorhexidine and silver sulfadiazine (3.4 percent), as compared with one case among the catheters impregnated with minocycline and rifampin (0.3 percent; relative risk, 12.05; 95 percent confidence interval, 1.59 to 90.9; P<0.002). Two patients died as a result of bloodstream infections associated with catheters impregnated with chlorhexidine and silver sulfadiazine. Among the catheters that remained in place for more than seven days, the rate of associated bloodstream infection was significantly higher for catheters impregnated with chlorhexidine and silver sulfadiazine than for catheters impregnated with minocycline and rifampin (11 of 172 catheters [6.4 percent] vs. 1 of 139 [0.7 percent], P=0.01). The rates of catheter-related bloodstream infection per 1000 catheter-days were 0.3 (95 percent confidence interval, 0.01 to 1.85) for catheters impregnated with minocycline and rifampin and 4.1 (95 percent confidence interval, 2.22 to 6.99) for catheters impregnated with chlorhexidine and silver sulfadiazine (P<0.001). Figure 1Figure 1
Kaplan–Meier Curves for Freedom from Bloodstream Infection with Catheters Impregnated with Either Minocycline and Rifampin or Chlorhexidine and Silver Sulfadiazine. shows the Kaplan–Meier estimates of the risk of catheter-related bloodstream infection according to duration of catheterization in each group and shows that catheters impregnated with minocycline and rifampin were superior (P=0.001 by log-rank test). The same conclusion was reached when we considered only the results from culture of the catheter tip (1 infection among 356 catheters [0.3 percent] vs. 11 among 382 [2.9 percent], P=0.006) or the subcutaneous segment (1 of 356 [0.3 percent] vs. 12 of 382 [3.1 percent], P=0.003).Enterococcus faecalis caused the single case of bloodstream infection related to a catheter impregnated with minocycline and rifampin. Organisms implicated in the 13 cases of bloodstream infection associated with catheters impregnated with chlorhexidine and silver sulfadiazine included coagulase-negative staphylococci (8 cases; in 1 a diphtheroid was also present), methicillin-resistant S. aureus, vancomycin-resistant E. faecalis, Enterobacter cloacae, Klebsiella pneumoniae, and Pseudomonas aeruginosa (1 case each). Fourteen of 115 colonized catheters (12 percent) resulted in bloodstream infection; there was no difference in the likelihood of infection between catheters colonized with coagulase-negative staphylococci and catheters colonized with other organisms. Catheters impregnated with minocycline and rifampin had a significant protective effect against catheter-related bloodstream infection by coagulase-negative staphylococci as compared with catheters impregnated with chlorhexidine and silver sulfadiazine (rate of infection, 0 of 356 vs. 8 of 382; P=0.008).
The clonal relation of isolates from blood and catheter cultures was confirmed by DNA typing in 13 of 14 cases (Figure 2Figure 2
Representative DNA-Fingerprint Patterns in Repetitive-Element Polymerase-Chain-Reaction Analysis of Isolates from Cultures of Catheter Segments, Peripheral Blood, and Skin from Seven Patients with Catheter-Related Bloodstream Infection.). Skin swabs were cultured at the time of the removal of the catheter from seven patients with catheter-related bloodstream infection. In five of these cases (71 percent), the culture yielded bacteria of the same species with a DNA-fingerprint pattern similar to that of the isolates from the catheter and the blood; a different organism grew from skin cultures in the other two patients (29 percent), suggesting that catheter infection may have originated from contamination of the catheter hub.Factors that may have increased the risk of catheter-related bloodstream infection in the univariate analysis (with P≤0.25 as the criterion) were entered into a multivariate logistic-regression model, which identified the following predisposing factors as significant (P≤0.05): catheterization for more than seven days, use of a catheter impregnated with chlorhexidine and silver sulfadiazine, and male sex (Table 2Table 2
Results of Univariate and Multivariate Analyses of Factors Associated with Catheter-Related Bloodstream Infection.).Analysis of data for only the first catheter insertion (698 catheters) also demonstrated that the use of catheters impregnated with minocycline and rifampin was associated with lower rates of colonization of the catheter than the use of catheters impregnated with chlorhexidine and silver sulfadiazine (79 of 359 catheters impregnated with chlorhexidine and silver sulfadiazine were colonized [22.0 percent], vs. 28 of 339 [8.3 percent] for minocycline and rifampin; relative risk, 2.66; 95 percent confidence interval, 1.78 to 4.0; P<0.001) and bloodstream infection (12 of 359 [3.3 percent] vs. 1 of 339 [0.3 percent]; relative risk, 11.33; 95 percent confidence interval, 1.48 to 83.3; P=0.003). Although there was a trend toward a lower risk of nosocomial bacteremia with catheters impregnated with minocycline and rifampin than with catheters impregnated with chlorhexidine and silver sulfadiazine (6.7 percent vs. 10.2 percent), the difference was not significant (P=0.12). There were no significant differences between the two groups in the proportions receiving therapy with vancomycin (23 percent vs. 25 percent) or antibiotics in general (89 percent vs. 90 percent) and the mean duration of stay in the intensive care unit (8.7 vs. 8.6 days).
Antimicrobial Susceptibility
The ranges of the minimal inhibitory concentrations and minimal bactericidal concentrations of minocycline and rifampin for S. epidermidis and enterococci were similar for isolates cultured from the two types of catheters (Table 3Table 3
Antimicrobial Susceptibility of Bacterial Isolates Cultured from Catheters.). Moreover, in the two cases in which the same organism was isolated from paired cultures of skin obtained before insertion and at the time of removal of a catheter impregnated with minocycline and rifampin (S. epidermidis in one case and enterococcus in the other), the minimal inhibitory concentrations and minimal bactericidal concentrations of minocycline and rifampin for the corresponding paired isolates were similar.Adverse Effects of the Catheters
There were no local or systemic hypersensitivity reactions associated with the use of either catheter.
Discussion
Recent comparative studies have shown that the use of central venous catheters impregnated either with minocycline and rifampin2 or with chlorhexidine and silver sulfadiazine3 is associated with lower rates of catheter colonization and bloodstream infection than the use of unimpregnated catheters. Although three smaller clinical trials (which studied 72, 282, and 308 catheters that could be evaluated)13-15 showed a nonsignificant trend toward lower rates of bloodstream infection with catheters impregnated with chlorhexidine and silver sulfadiazine than with unimpregnated catheters, none had sufficient power to determine that there were no differences. We compared two very differently prepared antiinfective catheters. As we hypothesized, our findings indicated that the antiinfective efficacy of catheters impregnated with minocycline and rifampin was superior to that of catheters impregnated with chlorhexidine and silver sulfadiazine.
The majority of cases of catheter-related bloodstream infection are associated with the short-term use of noncuffed central venous catheters.16 On average, 5 percent2,3,14,15 of the 3 million short-term, unimpregnated central venous catheters that are inserted annually in the United States lead to bloodstream infection,16 resulting in about 150,000 cases of catheter-related bloodstream infection a year. Our findings of remarkably low rates of catheter-related bloodstream infection (0.3 percent) and catheter colonization (7.9 percent) associated with the use of catheters impregnated with minocycline and rifampin are similar to previously reported rates.2 However, we found rates of catheter colonization (22.8 percent) and bloodstream infection (3.4 percent) associated with the use of catheters impregnated with chlorhexidine and silver sulfadiazine that were higher than those reported by Maki and colleagues (13.5 percent and 1 percent, respectively).3 The differences in rates of colonization of catheters could be attributed, at least in part, to our use of roll-plate and sonication cultures of both the tips and subcutaneous segments, as compared with the use by Maki et al. of only roll-plate culture of the catheter tips alone.3 As in other reports,7,17 the roll-plate culture had a limited sensitivity for the diagnosis of catheter colonization (78 of 115 catheters [68 percent]) and catheter-related bloodstream infection (12 of 14 [86 percent]) in our study.
Unlike catheters impregnated with minocycline and rifampin, in which antimicrobial activity is present on both the external and the internal surfaces of the catheter, the antimicrobial activity of catheters impregnated with chlorhexidine and silver sulfadiazine is limited to the external surface. The difference might be an important determinant of the difference in efficacy between these two antimicrobial-impregnated catheters. For instance, catheters impregnated with chlorhexidine and silver sulfadiazine reduced colonization of the external surface as compared with uncoated catheters in studies in which the roll-plate method alone was used to culture only the catheter tips2 or both the catheter tips and the subcutaneous segments.14,15 Our use of sonication cultures that retrieve organisms from both the external and internal surfaces is justified by the role of luminal colonization in causing catheter-related bloodstream infection.18 Other factors that may have contributed to the superior efficacy of the catheters impregnated with minocycline and rifampin include the particular method used to incorporate the antimicrobial agents into the catheter material and the resulting concentration and availability of those agents on the catheter surface.
Although antimicrobial resistance is an issue of potential concern, we and others2 have, so far, found a very low likelihood that antibiotic resistance will result from the use of antimicrobial-impregnated catheters. However, continued surveillance for resistance is required as part of the further clinical use of such catheters. Although it is possible that the use of any antiinfective catheter that reduces ultrastructural colonization may decrease the likelihood of the development of resistance to systemically administered antibiotics such as vancomycin,19 the actual effects of the use of antimicrobial-impregnated catheters on infection-control measures require further evaluation.
In conclusion, our results demonstrate that the capacity of catheters impregnated with minocycline and rifampin to resist infection is superior to that of catheters impregnated with chlorhexidine and silver sulfadiazine, particularly in patients who require vascular access for seven or more days. Despite their proven efficacy, antimicrobial-impregnated catheters should complement rather than replace adequate aseptic practices.10,11
Presented in part as an abstract (LB-22) at the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, September 28–October 1, 1997.
Supported by funds from Cook Critical Care, Bloomington, Indiana; the Department of Veterans Affairs, Washington, D.C.; and the University Cancer Foundation at the University of Texas M.D. Anderson Cancer Center, Houston.
Impregnation of catheters with minocycline and rifampin is described in two patents that are the property of Baylor College of Medicine and the University of Texas M.D. Anderson Cancer Center, Houston. Dr. Darouiche (an employee of Baylor College of Medicine) and Dr. Raad (an employee of the University of Texas M.D. Anderson Cancer Center) are coinventors of the two patented methods. Both patents were licensed by Cook Critical Care, Bloomington, Indiana, with royalty rights to Baylor College of Medicine and the University of Texas M.D. Anderson Cancer Center. The inventors receive a percentage of the royalties according to the official policies of each academic institution. None of the authors, including Dr. Darouiche and Dr. Raad, have other financial links to Cook Critical Care or other catheter-manufacturing companies.
We are indebted to Daniel M. Musher, M.D., and Gerald P. Bodey, M.D., for serving on the study monitoring board and for their critical review of the manuscript.
Source Information
From the Departments of Medicine (R.O.D., R.L.H.), Physical Medicine and Rehabilitation (R.O.D.), Family and Community Medicine (J.I.T.), and Anesthesiology (O.C.W.), Baylor College of Medicine and Veterans Affairs Medical Center, Houston; the Department of Medical Subspecialties, University of Texas M.D. Anderson Cancer Center, Houston (I.I.R., H.H., R.H.); the Department of Anesthesiology, University of Massachusetts Medical Center, Worcester (S.O.H.); the Departments of Surgery (A.G.) and Medicine (J.B.), University of Florida College of Medicine, Gainesville; the Department of Medicine, Southern Illinois University School of Medicine, Springfield (N.K.); and the Department of Medicine, University of Texas Medical Branch, Galveston (G.M.).
Address reprint requests to Dr. Darouiche at the Veterans Affairs Medical Center, Infectious Disease Section (Rm. 4B-370), 2002 Holcombe Blvd., Houston, TX 77030, or at darouiche.rabih.o@houston.va.gov.
Other members of the Catheter Study Group are listed in the Appendix.
Appendix
In addition to the authors, the following members of the Catheter Study Group participated in the clinical trial: C. Robertson, M. Wall, J. Jones, M. Mansouri, C. Stewart, and S. Dunbar (Baylor College of Medicine, Houston); J. Dupuis, A. Buzaid, K. Price, A. El-Rahwan, J. Abbas, and S. Sidarous (University of Texas M.D. Anderson Cancer Center, Houston); I. Toth, K. Longtine, and A. Breuggemann (University of Massachusetts Medical Center, Worcester); K. Rand (University of Florida College of Medicine, Gainesville); S. Bjornson (University of Cincinnati Medical Center, Cincinnati); and P. Falk (University of Texas Medical Branch, Galveston).
- References
References
1
Pittet D ,Tarara D ,Wenzel RP . Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 1994;271:1598-1601
CrossRef | Web of Science | Medline2
Raad I ,Darouiche R ,Dupuis J , et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: a randomized, double-blind trial. Ann Intern Med 1997;127:267-274
Web of Science | Medline3
Maki DG ,Stolz SM ,Wheeler S ,Mermel LA . Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial. Ann Intern Med 1997;127:257-266
Web of Science | Medline4
Raad I ,Darouiche R ,Hachem R ,Sacilowski M ,Bodey GP . Antibiotics and prevention of microbial colonization of catheters. Antimicrob Agents Chemother 1995;39:2397-2400
Web of Science | Medline5
Raad I ,Darouiche R ,Hachem R ,Mansouri M ,Bodey GP . The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis 1996;173:418-424
CrossRef | Web of Science | Medline6
Maki DG ,Weise CE ,Sarafin HW . A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 1977;296:1305-1309
Full Text | Web of Science | Medline7
Sherertz RJ ,Raad II ,Belani A , et al. Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol 1990;28:76-82
Web of Science | Medline8
Clarridge JE III ,Raich TJ ,Sjosted A , et al. Characterization of two unusual clinically significant Francisella strains. J Clin Microbiol 1996;34:1995-2000
Web of Science | Medline9
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. 4th ed. Vol. 17. No. 2. Wayne, Pa.: National Committee for Clinical Laboratory Standards, 1997. (NCCLS document no. M7-A4.)
10
Pearson ML, Hospital Infection Control Practices Advisory Committee
CrossRef | Web of Science | Medline11
Pearson ML, Hospital Infection Control Practices Advisory Committee
Medline12
SAS user's guide: statistics, version 6. Cary, N.C.: SAS Institute, 1991.
13
Pemberton LB ,Ross V ,Cuddy P ,Kremer H ,Fessler T ,McGurk E . No difference in catheter sepsis between standard and antiseptic central venous catheters: a prospective randomized trial. Arch Surg 1996;131:986-989
Web of Science | Medline14
Tennenberg S ,Lieser M ,McCurdy B , et al. A prospective randomized trial of an antibiotic- and antiseptic-coated central venous catheter in the prevention of catheter-related infections. Arch Surg 1997;132:1348-1351
Web of Science | Medline15
Heard SO ,Wagle M ,Vijayakumar E , et al. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Arch Intern Med 1998;158:81-87
CrossRef | Web of Science | Medline16
Raad II ,Bodey GP . Infectious complications of indwelling vascular catheters. Clin Infect Dis 1992;15:197-208
CrossRef | Web of Science | Medline17
Sherertz RJ ,Heard SO ,Raad II . Diagnosis of triple-lumen catheter infection: comparison of roll plate, sonication, and flushing methodologies. J Clin Microbiol 1997;35:641-646
Web of Science | Medline18
Salzman MB ,Isenberg HD ,Shapiro JF ,Lipsitz PJ ,Rubin LG . A prospective study of the catheter hub as the portal of entry for microorganisms causing catheter-related sepsis in neonates. J Infect Dis 1993;167:487-490
CrossRef | Web of Science | Medline19
Raad II ,Darouiche RO ,Hachem R , et al. Antimicrobial durability and rare ultrastructural colonization of indwelling central catheters coated with minocycline and rifampin. Crit Care Med 1998;26:219-224
CrossRef | Web of Science | Medline
- Citing Articles (266)
Citing Articles
1
Selma O. Algra, Mieke M. P. Driessen, Alvin W. L. Schadenberg, Antonius N. J. Schouten, Felix Haas, Casper W. Bollen, Michiel L. Houben, Nicolaas J. G. Jansen. (2012) Bedside prediction rule for infections after pediatric cardiac surgery. Intensive Care Medicine
CrossRef2
R. P. Allaker, M. A. Vargas-Reus, G. G. Ren. 2011. Nanometals as Antimicrobials. , 327-350.
CrossRef3
Kevin W. Lobdell, Sotiris Stamou, Juan A. Sanchez. (2011) Hospital-Acquired Infections. Surgical Clinics of North America
CrossRef4
Hongwei Chai, Lei Guo, Xiantao Wang, Yuping Fu, Junlin Guan, Lili Tan, Ling Ren, Ke Yang. (2011) Antibacterial effect of 317L stainless steel contained copper in prevention of implant-related infection in vitro and in vivo. Journal of Materials Science: Materials in Medicine 22:11, 2525-2535
CrossRef5
Jehuda Soleman, Serge Marbacher, Javier Fandino, Ali Reza Fathi. (2011) Is the use of antibiotic-impregnated external ventricular drainage beneficial in the management of iatrogenic ventriculitis?. Acta Neurochirurgica
CrossRef6
M. Pollini, F. Paladini, M. Catalano, A. Taurino, A. Licciulli, A. Maffezzoli, A. Sannino. (2011) Antibacterial coatings on haemodialysis catheters by photochemical deposition of silver nanoparticles. Journal of Materials Science: Materials in Medicine 22:9, 2005-2012
CrossRef7
Mark Gunst, Kazuhide Matsushima, Sue Vanek, Richard Gunst, Shahid Shafi, Heidi Frankel. (2011) Peripherally Inserted Central Catheters May Lower the Incidence of Catheter-Related Blood Stream Infections in Patients in Surgical Intensive Care Units. Surgical Infections 12:4, 279-282
CrossRef8
Kristina R. Weeks, Christine A. Goeschel, Sara E. Cosgrove, Mark Romig, Sean M. Berenholtz. (2011) Prevention of Central Line–Associated Bloodstream Infections: A Journey Toward Eliminating Preventable Harm. Current Infectious Disease Reports 13:4, 343-349
CrossRef9
Michael J. Costanza, Kwame S. Amankwah, Muhammad Asad Khan, Sriram S. Narsipur, Vivian Gahtan. (2011) Angioaccess for Hemodialysis. Current Problems in Surgery 48:7, 443-517
CrossRef10
Leanne M. Aitken, Ged Williams, Maurene Harvey, Stijn Blot, Ruth Kleinpell, Sonia Labeau, Andrea Marshall, Gillian Ray-Barruel, Patricia A. Moloney-Harmon, Wayne Robson, Alexander P. Johnson, Pang Nguk Lan, Tom Ahrens. (2011) Nursing considerations to complement the Surviving Sepsis Campaign guidelines. Critical Care Medicine 39:7, 1800-1818
CrossRef11
Cláudia Sousa, Mariana Henriques, Rosário Oliveira. (2011) Mini-review: Antimicrobial central venous catheters – recent advances and strategies. Biofouling 27:6, 609-620
CrossRef12
Ammar T. Qureshi, W. Todd Monroe, Mandi J. Lopez, Marlene E. Janes, Vinod Dasa, Sunggook Park, Alborz Amirsadeghi, Daniel J. Hayes. (2011) Biocompatible/bioabsorbable silver nanocomposite coatings. Journal of Applied Polymer Science 120:5, 3042-3053
CrossRef13
Anne-Marie Chaftari, Christelle Kassis, Hiba El Issa, Iba Al Wohoush, Ying Jiang, Gopikishan Rangaraj, Brenda Caillouet, S. Egbert Pravinkumar, Ray Y. Hachem, Issam I. Raad. (2011) Novel approach using antimicrobial catheters to improve the management of central line-associated bloodstream infections in cancer patients. Cancer 117:11, 2551-2558
CrossRef14
Kisaki Shimazu, Yukihiro Takahashi, Hiroyuki Karibe, Fusako Mitsuhashi, Kiyoshi Konishi. (2011) Contribution of phosphoglucosamine mutase to determination of bacterial cell morphology in Streptococcus gordonii. Odontology
CrossRef15
N. P. O'Grady, M. Alexander, L. A. Burns, E. P. Dellinger, J. Garland, S. O. Heard, P. A. Lipsett, H. Masur, L. A. Mermel, M. L. Pearson, I. I. Raad, A. G. Randolph, M. E. Rupp, S. Saint, . (2011) Guidelines for the Prevention of Intravascular Catheter-related Infections. Clinical Infectious Diseases 52:9, e162-e193
CrossRef16
Naomi P. O'Grady, Mary Alexander, Lillian A. Burns, E. Patchen Dellinger, Jeffrey Garland, Stephen O. Heard, Pamela A. Lipsett, Henry Masur, Leonard A. Mermel, Michele L. Pearson, Issam I. Raad, Adrienne G. Randolph, Mark E. Rupp, Sanjay Saint. (2011) Guidelines for the prevention of intravascular catheter-related infections. American Journal of Infection Control 39:4, S1-S34
CrossRef17
N. P. O'Grady, M. Alexander, L. A. Burns, E. P. Dellinger, J. Garland, S. O. Heard, P. A. Lipsett, H. Masur, L. A. Mermel, M. L. Pearson, I. I. Raad, A. G. Randolph, M. E. Rupp, S. Saint, . (2011) Summary of Recommendations: Guidelines for the Prevention of Intravascular Catheter-related Infections. Clinical Infectious Diseases 52:9, 1087-1099
CrossRef18
Lynn N. Fitzgibbons, Darcy L. Puls, Kimberly Mackay, Graeme N. Forrest. (2011) Management of Gram-Positive Coccal Bacteremia and Hemodialysis. American Journal of Kidney Diseases 57:4, 624-640
CrossRef19
J. Matthias Walz, Rui L. Avelar, Stephen O. Heard. (2011) Coated central venous catheters: Mortality, illness severity?. Critical Care Medicine 39:4, 923
CrossRef20
Bin Pan, Renzheng Huang, Likang Zheng, Chen Chen, Shiqing Han, Di Qu, Mingli Zhu, Ping Wei. (2011) Thiazolidione derivatives as novel antibiofilm agents: Design, synthesis, biological evaluation, and structure–activity relationships. European Journal of Medicinal Chemistry 46:3, 819-824
CrossRef21
Charmaine E Lok, Michele H Mokrzycki. (2011) Prevention and management of catheter-related infection in hemodialysis patients. Kidney International 79:6, 587-598
CrossRef22
David J. Weber, William A. Rutala. (2011) Central Line–Associated Bloodstream Infections: Prevention and Management. Infectious Disease Clinics of North America 25:1, 77-102
CrossRef23
Elizabeth R. Ramos, Ruth Reitzel, Ying Jiang, Ray Y. Hachem, Ann Marie Chaftari, Roy F. Chemaly, Brenda Hackett, S. Egbert Pravinkumar, Joseph Nates, Jeffrey J. Tarrand, Issam I. Raad. (2011) Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters: More than 0.5 million catheter days and 7 years of clinical experience*. Critical Care Medicine 39:2, 245-251
CrossRef24
Alejandro R. Rodriguez, Rafael E. Carrion. (2011) Antibiotic Impregnated Penile Prosthesis. The Journal of Urology 185:2, 619
CrossRef25
T.F. Moriarty, A.H.C. Poulsson, E.T.J. Rochford, R.G. Richards. 2011. Bacterial Adhesion and Biomaterial Surfaces. , 75-100.
CrossRef26
Catherine M. Santos, Maria Celeste R. Tria, Regina Aileen May V. Vergara, Farid Ahmed, Rigoberto C. Advincula, Debora F. Rodrigues. (2011) Antimicrobial graphene polymer (PVK-GO) nanocomposite films. Chemical Communications 47:31, 8892
CrossRef27
Stephen M. Schexnayder, Elizabeth A. Storm, Michael H. Stroud, Michele M. Moss, Ashley S. Ross, Richard T. Fiser, Muayyad Tailounie, Xiomara Garcia-Casal. 2011. Pediatric Vascular Access and Centeses. , 139-163.
CrossRef28
Kitty K.K. Ho, Nerida Cole, Renxun Chen, Mark D.P. Willcox, Scott A. Rice, Naresh Kumar. (2010) Characterisation and in vitro activities of surface attached dihydropyrrol-2-ones against Gram-negative and Gram-positive bacteria. Biofouling 26:8, 913-921
CrossRef29
H. Wang, T. Huang, J. Jing, J. Jin, P. Wang, M. Yang, W. Cui, Y. Zheng, H. Shen. (2010) Effectiveness of different central venous catheters for catheter-related infections: a network meta-analysis. Journal of Hospital Infection 76:1, 1-11
CrossRef30
Jie Li, Judy F. Burnham, Trey Lemley, Robert M. Britton. (2010) Citation Analysis: Comparison of Web of Science®, Scopus™, SciFinder®, and Google Scholar. Journal of Electronic Resources in Medical Libraries 7:3, 196-217
CrossRef31
Paul Chittick, Robert J. Sherertz. (2010) Recognition and prevention of nosocomial vascular device and related bloodstream infections in the intensive care unit. Critical Care Medicine 38, S363-S372
CrossRef32
2010. Strategies for Prevention of Device-Related Nosocomial Infections. , 265-336.
CrossRef33
R.F. Chemaly, P.S. Sharma, S. Youssef, D. Gerber, P. Hwu, S.S. Hanmod, Y. Jiang, R.Y. Hachem, I.I. Raad. (2010) The efficacy of catheters coated with minocycline and rifampin in the prevention of catheter-related bacteremia in cancer patients receiving high-dose interleukin-2. International Journal of Infectious Diseases 14:7, e548-e552
CrossRef34
Rupal I Mehta, Rashi I Mehta, Orestes E Solis, Reza Jahan, Noriko Salamon, Jonathan M Tobis, William H Yong, Harry V Vinters, Michael C Fishbein. (2010) Hydrophilic polymer emboli: an under-recognized iatrogenic cause of ischemia and infarct. Modern Pathology 23:7, 921-930
CrossRef35
Amparo M. Gallardo-Moreno, Miguel A. Pacha-Olivenza, María-Coronada Fernández-Calderón, Ciro Pérez-Giraldo, José M. Bruque, María-Luisa González-Martín. (2010) Bactericidal behaviour of Ti6Al4V surfaces after exposure to UV-C light. Biomaterials 31:19, 5159-5168
CrossRef36
Raquel Gutiérrez-González, Gregorio R. Boto. (2010) Do antibiotic-impregnated catheters prevent infection in CSF diversion procedures? Review of the literature. Journal of Infection 61:1, 9-20
CrossRef37
James S. Harrop, Ashwini D. Sharan, John Ratliff, Srini Prasad, Pascal Jabbour, James J. Evans, Erol Veznedaroglu, David W. Andrews, Mitchell Maltenfort, Kenneth Liebman, Phyllis Flomenberg, Bevin Sell, Amy S. Baranoski, Claudette Fonshell, David Reiter, Robert H. Rosenwasser. (2010) Impact of a Standardized Protocol and Antibiotic-Impregnated Catheters on Ventriculostomy Infection Rates in Cerebrovascular Patients. Neurosurgery 67:1, 187-191
CrossRef38
Supriya Narasimhan, Saima Aslam, Peter H. Lin, Carlos F. Bechara, Mohammad D. Mansouri, Rabih O. Darouiche. (2010) Bacterial translocation across ePTFE vascular graft surfaces. Journal of Infection 60:6, 486-490
CrossRef39
Stephen E McKim, Culley C Carson III. (2010) AMS 700™ inflatable penile prosthesis with InhibiZone ®. Expert Review of Medical Devices 7:3, 311-317
CrossRef40
Mark H. Wilcox, Robert C. Spencer. 2010. Healthcare-Associated Infections. .
CrossRef41
B. PARSONS. 2010. Sterilisation of drug–device combination products. , 395-435.
CrossRef42
Mohammad D. Mansouri, Timothy B. Boone, Rabih O. Darouiche. (2009) Comparative Assessment of Antimicrobial Activities of Antibiotic-Treated Penile Prostheses. European Urology 56:6, 1039-1046
CrossRef43
Francisco Esteve, Miquel Pujol, Javier Ariza, Francisco Gudiol, Ricard Verdaguer, María Cisnal, María José Argerich, Rafael Mañez. (2009) Impacto de un programa de prevención de la bacteriemia relacionada con el catéter en una unidad de cuidados intensivos de un hospital terciario. Enfermedades Infecciosas y Microbiología Clínica 27:10, 561-565
CrossRef44
Murat Karaman, Adem Emre İlhan, Gökçe Dereci, Arman Tek. (2009) Determination of optimum dosage of intraoperative single dose dexamethasone in pediatric tonsillectomy and adenotonsillectomy. International Journal of Pediatric Otorhinolaryngology 73:11, 1513-1515
CrossRef45
Micah R. Chan, Alexander S. Yevzlin. (2009) Tunneled Dialysis Catheters: Recent Trends and Future Directions. Advances in Chronic Kidney Disease 16:5, 386-395
CrossRef46
Natalia Hagau, Daniela Studnicska, Rodica L Gavrus, Gabriela Csipak, Radu Hagau, Adriana VC Slavcovici. (2009) Central venous catheter colonization and catheter-related bloodstream infections in critically ill patients: a comparison between standard and silver-integrated catheters. European Journal of Anaesthesiology 26:9, 752-758
CrossRef47
L.F.A. Camargo, A.R. Marra, G.L. Büchele, A.M.C. Sogayar, R.G.R. Cal, J.M.A. de Sousa, E. Silva, E. Knobel, M.B. Edmond. (2009) Double-lumen central venous catheters impregnated with chlorhexidine and silver sulfadiazine to prevent catheter colonisation in the intensive care unit setting: a prospective randomised study. Journal of Hospital Infection 72:3, 227-233
CrossRef48
Walter Zingg, Alexander Imhof, Marco Maggiorini, Reto Stocker, Emanuela Keller, Christian Ruef. (2009) Impact of a prevention strategy targeting hand hygiene and catheter care on the incidence of catheter-related bloodstream infections*. Critical Care Medicine 37:7, 2167-2173
CrossRef49
LINDA K. HANSEN, MARY BROWN, DAVID JOHNSON, DONALD F. PALME II, CHARLES LOVE, RABIH DAROUICHE. (2009) In Vivo Model of Human Pathogen Infection and Demonstration of Efficacy by an Antimicrobial Pouch for Pacing Devices. Pacing and Clinical Electrophysiology 32:7, 898-907
CrossRef50
Alessandra Agostinho, Garth James, Oussama Wazni, Mark Citron, Bruce D. Wilkoff. (2009) Inhibition of Staphylococcus aureus Biofilms by a Novel Antibacterial Envelope for Use with Implantable Cardiac Devices. Clinical and Translational Science 2:3, 193-198
CrossRef51
Renxun Chen, Nerida Cole, Mark D.P. Willcox, Josephine Park, Riaz Rasul, Elizabeth Carter, Naresh Kumar. (2009) Synthesis, characterization and in vitro activity of a surface-attached antimicrobial cationic peptide. Biofouling 25:6, 517-524
CrossRef52
Matthew R. Goede, Craig M. Coopersmith. (2009) Catheter-Related Bloodstream Infection. Surgical Clinics of North America 89:2, 463-474
CrossRef53
Kathie L. Rogers, Paul D. Fey, Mark E. Rupp. (2009) Coagulase-Negative Staphylococcal Infections. Infectious Disease Clinics of North America 23:1, 73-98
CrossRef54
Andrew M. Naidech, Bernard R. Bendok, Paul Tamul, Sarice L. Bassin, Charles M. Watts, H. Hunt Batjer, Thomas P. Bleck. (2009) Medical Complications Drive Length of Stay After Brain Hemorrhage: A Cohort Study. Neurocritical Care 10:1, 11-19
CrossRef55
Juliet C. Hockenhull, Kerry M. Dwan, Godfrey W. Smith, Carrol L. Gamble, Angela Boland, Tom J. Walley, Rumona C. Dickson. (2009) The clinical effectiveness of central venous catheters treated with anti-infective agents in preventing catheter-related bloodstream infections: A systematic review*. Critical Care Medicine 37:2, 702-712
CrossRef56
Sacha Noimark, Charles W. Dunnill, Michael Wilson, Ivan P. Parkin. (2009) The role of surfaces in catheter-associated infections. Chemical Society Reviews 38:12, 3435
CrossRef57
M.D.P. Willcox, E.B.H. Hume, Y. Aliwarga, N. Kumar, N. Cole. (2008) A novel cationic-peptide coating for the prevention of microbial colonization on contact lenses. Journal of Applied Microbiology 105:6, 1817-1825
CrossRef58
Nikolaos Bessias, Kosmas I. Paraskevas, Effie Tziviskou, Vassilios Andrikopoulos. (2008) Vascular access in elderly patients with end-stage renal disease. International Urology and Nephrology 40:4, 1133-1142
CrossRef59
Saima Aslam. (2008) Effect of antibacterials on biofilms. American Journal of Infection Control 36:10, S175.e9-S175.e11
CrossRef60
Anna L Casey, Leonard A Mermel, Peter Nightingale, Tom SJ Elliott. (2008) Antimicrobial central venous catheters in adults: a systematic review and meta-analysis. The Lancet Infectious Diseases 8:12, 763-776
CrossRef61
Hans-Heinrich Wolf, Malte Leithäuser, Georg Maschmeyer, Hans Salwender, Ulrike Klein, Iris Chaberny, Florian Weissinger, Dieter Buchheidt, Markus Ruhnke, Gerlinde Egerer, Oliver Cornely, Gerd Fätkenheuer, Sabine Mousset. (2008) Central venous catheter-related infections in hematology and oncology. Annals of Hematology 87:11, 863-876
CrossRef62
Amy Dwyer. (2008) REDUCING TUNNELED HEMODIALYSIS CATHETER MORBIDITY: Surface-Treated Catheters-A Review. Seminars in Dialysis 21:6, 542-546
CrossRef63
Daniel P. McQuillen, Russell M. Petrak, Ronald B. Wasserman, Ronald G. Nahass, Jason A. Scull, Lawrence P. Martinelli. (2008) The Value of Infectious Diseases Specialists: Non–Patient Care Activities. Clinical Infectious Diseases 47:8, 1051-1063
CrossRef64
Jonas Marschall, Leonard A. Mermel, David Classen, Kathleen M. Arias, Kelly Podgorny, Deverick J. Anderson, Helen Burstin, David P. Calfee, Susan E. Coffin, Erik R. Dubberke, Victoria Fraser, Dale N. Gerding, Frances A. Griffin, Peter Gross, Keith S. Kaye, Michael Klompas, Evelyn Lo, Lindsay Nicolle, David A. Pegues, Trish M. Perl, Sanjay Saint, Cassandra D. Salgado, Robert A. Weinstein, Robert Wise, Deborah S. Yokoe. (2008) Strategies to Prevent Central Line–Associated Bloodstream Infections in Acute Care Hospitals • . Infection Control and Hospital Epidemiology 29:S1, S22-S30
CrossRef65
P Nieboer, E G E de Vries, N H Mulder, S Rodenhuis, M Bontenbal, E van der Wall, Q G van Hoesel, W M Smit, P Hupperets, E E Voest, M A Nooij, H M Boezen, W T A van der Graaf. (2008) Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients. Bone Marrow Transplantation 42:7, 475-481
CrossRef66
Ruth E Gilbert, Melissa Harden. (2008) Effectiveness of impregnated central venous catheters for catheter related blood stream infection: a systematic review. Current Opinion in Internal Medicine 7:4, 345-355
CrossRef67
I. Raad, R. Reitzel, Y. Jiang, R. F. Chemaly, T. Dvorak, R. Hachem. (2008) Anti-adherence activity and antimicrobial durability of anti-infective-coated catheters against multidrug-resistant bacteria. Journal of Antimicrobial Chemotherapy 62:4, 746-750
CrossRef68
Ruth E Gilbert, Melissa Harden. (2008) Effectiveness of impregnated central venous catheters for catheter related blood stream infection: a systematic review. Current Opinion in Infectious Diseases 21:3, 235-245
CrossRef69
Shunmugaperumal Tamilvanan, Narayanan Venkateshan, Annick Ludwig. (2008) The potential of lipid- and polymer-based drug delivery carriers for eradicating biofilm consortia on device-related nosocomial infections. Journal of Controlled Release 128:1, 2-22
CrossRef70
Primrose P. E. Freestone, Richard D. Haigh, Mark Lyte. (2008) Catecholamine Inotrope Resuscitation of Antibiotic‐Damaged Staphylococci and Its Blockade by Specific Receptor Antagonists. The Journal of Infectious Diseases 197:7, 1044-1052
CrossRef71
Lars Fischer, Phillip Knebel, Steffen Schröder, Thomas Bruckner, Markus K. Diener, Roland Hennes, Klaus Buhl, Bruno Schmied, Christoph M. Seiler. (2008) Reasons for Explantation of Totally Implantable Access Ports: A Multivariate Analysis of 385 Consecutive Patients. Annals of Surgical Oncology 15:4, 1124-1129
CrossRef72
Daniel Z Uslan. (2008) Infections of electrophysiologic cardiac devices. Expert Review of Medical Devices 5:2, 183-195
CrossRef73
Prabha Ramritu, Kate Halton, Peter Collignon, David Cook, David Fraenkel, Diana Battistutta, Michael Whitby, Nicholas Graves. (2008) A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units. American Journal of Infection Control 36:2, 104-117
CrossRef74
Jesús Fortún. (2008) Infecciones asociadas a dispositivos intravasculares utilizados para la terapia de infusión. Enfermedades Infecciosas y Microbiología Clínica 26:3, 168-174
CrossRef75
Bertrand Souweine, Anne Elisabeth Heng, Claire Aumeran, Fabrice Thiollière, Nicole Gazuy, Patrice Deteix, Ousmane Traoré. (2008) Do antibiotics administered at the time of central venous catheter removal interfere with the evaluation of colonization?. Intensive Care Medicine 34:2, 286-291
CrossRef76
SM Lyon, M Given, NL Marshall. (2008) Interventional radiology in the provision and maintenance of long-term central venous access. Journal of Medical Imaging and Radiation Oncology 52:1, 10-17
CrossRef77
Demetrios Demetriades, Addison May, Hugh Gamble. (2008) When Does a Centers for Disease Control and Prevention Recommendation Become Standard of Care? Perhaps in the Courtroom. American College of Surgeons Mock Trial: Line Sepsis Liability. Journal of the American College of Surgeons 206:2, 370-375
CrossRef78
B. S. Niël-Weise, T. Stijnen, P. J. Broek. (2007) Anti-infective-treated central venous catheters: a systematic review of randomized controlled trials. Intensive Care Medicine 33:12, 2058-2068
CrossRef79
Issam Raad, Hend Hanna, Dennis Maki. (2007) Intravascular catheter-related infections: advances in diagnosis, prevention, and management. The Lancet Infectious Diseases 7:10, 645-657
CrossRef80
Nicolas Penel, Jean-Charles Neu, Stéphanie Clisant, Helga Hoppe, Patrick Devos, Yazdan Yazdanpanah. (2007) Risk factors for early catheter-related infections in cancer patients. Cancer 110:7, 1586-1592
CrossRef81
Anjali Chelliah, Kateri H. Heydon, Theoklis E. Zaoutis, Susan L. Rettig, Troy E. Dominguez, Richard Lin, Sujata Patil, Chris Feudtner, Keith H. St. John, Louis M. Bell, Susan E. Coffin. (2007) Observational Trial of Antibiotic-Coated Central Venous Catheters in Critically Ill Pediatric Patients. The Pediatric Infectious Disease Journal 26:9, 816-820
CrossRef82
M.B.C. Fontana, M.C.F. Bastos, A. Brandelli. (2007) Peptide-like substances as antimicrobial barriers to Corynebacterium sp. adhesion to silicone catheters. Letters in Applied Microbiology 45:3, 324-329
CrossRef83
Marta Fernandez Sampedro, Robin Patel. (2007) Infections Associated with Long-Term Prosthetic Devices. Infectious Disease Clinics of North America 21:3, 785-819
CrossRef84
Douglas J.E. Schuerer, Jeanne E. Zack, James Thomas, Ingrid B. Borecki, Carrie S. Sona, Marilyn E. Schallom, Melissa Venker, Jennifer L. Nemeth, Myrna R. Ward, Linda Verjan, David K. Warren, Victoria J. Fraser, John E. Mazuski, Walter A. Boyle, Timothy G. Buchman, Craig M. Coopersmith. (2007) Effect of Chlorhexidine/Silver Sulfadiazine-Impregnated Central Venous Catheters in an Intensive Care Unit with a Low Blood Stream Infection Rate after Implementation of an Educational Program: A Before–After Trial. Surgical Infections 8:4, 445-454
CrossRef85
Matthew C Byrnes, Craig M Coopersmith. (2007) Prevention of catheter-related blood stream infection. Current Opinion in Critical Care 13:4, 411-415
CrossRef86
Philippe Eggimann. (2007) Prevention of intravascular catheter infection. Current Opinion in Infectious Diseases 20:4, 360-369
CrossRef87
Helen C Hamilton, David Foxcroft, Helen C Hamilton. 2007. Central venous access sites for the prevention of venous thrombosis, stenosis and infection in patients requiring long-term intravenous therapy. .
CrossRef88
T.S.J. Elliott. (2007) An update on antimicrobial central venous catheters. Journal of Hospital Infection 65, 34-38
CrossRef89
Meital Zilberman, Alon Navon, Hana Sandovsky-Losica, Esther Segal. (2007) Biomedical coatings based on chitin soluble extract for inhibition of fungal adhesion to polymeric surfaces. Journal of Biomedical Materials Research Part A 81A:2, 392-398
CrossRef90
V. Ruggeri, I. Francolini, G. Donelli, A. Piozzi. (2007) Synthesis, characterization, andin vitro activity of antibiotic releasing polyurethanes to prevent bacterial resistance. Journal of Biomedical Materials Research Part A 81A:2, 287-298
CrossRef91
Dilek Kilic, Canan Agalar, Eylem Ozturk, Emir B. Denkbas, Abdullah Cime, Fatih Agalar. (2007) ANTIMICROBIAL ACTIVITY OF CEFAZOLIN-IMPREGNATED MESH GRAFTS. ANZ Journal of Surgery 77:4, 256-260
CrossRef92
Mohammad D. Mansouri, Rabih O. Darouiche. (2007) In vitro antimicrobial activity of N-acetylcysteine against bacteria colonising central venous catheters. International Journal of Antimicrobial Agents 29:4, 474-476
CrossRef93
Elias Anaissie. (2007) Antimicrobial coating of central venous catheters: Show me the data*. Critical Care Medicine 35:4, 1197-1199
CrossRef94
Pierre Kalfon, Cyrille de Vaumas, D??sir?? Samba, Eric Boulet, Jean-Yves Lefrant, Daniel Eyraud, Thierry Lherm, Fran??ois Santoli, Walid Naija, Bruno Riou. (2007) Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients*. Critical Care Medicine 35:4, 1032-1039
CrossRef95
Milind D. Khare, Sayed S. Bukhari, Andrew Swann, Paul Spiers, Iain McLaren, Jenny Myers. (2007) Reduction of catheter-related colonisation by the use of a silver zeolite-impregnated central vascular catheter in adult critical care. Journal of Infection 54:2, 146-150
CrossRef96
R.J. Pratt, C.M. Pellowe, J.A. Wilson, H.P. Loveday, P.J. Harper, S.R.L.J. Jones, C. McDougall, M.H. Wilcox. (2007) epic2: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in England. Journal of Hospital Infection 65, S1-S59
CrossRef97
Norio Ohmagari. (2007) Cost effective ways of the prevention of intravascular catheter-related infections. Nihon Shuchu Chiryo Igakukai zasshi 14:4, 516-517
CrossRef98
Vesna Mioljevic, Vesna Suljagic, Biljana Jovanovic, Jelena Gligorijevic, Snezana Jovanovic, Natasa Mazic. (2007) Risk factors for the appearance of central venous catheters colonization. Vojnosanitetski pregled 64:11, 760-764
CrossRef99
Cristobal León, Emilio Bouza, Carmen Fariñas, Jesús Fortún, Elías García Sánchez, Josefina Liñares, Pedro Llinares, Emilio Maseda, Jesús Rodríguez-Baño, Óscar Rodríguez, M. Rovira. (2007) Update on vascular catheter-related infections. Enfermedades Infecciosas y Microbiología Clínica 25, 37-46
CrossRef100
Colin P. McCoy, Clare Rooney, David S. Jones, Sean P. Gorman, Mark Nieuwenhuyzen. (2006) Rational Design of a Dual-Mode Optical and Chemical Prodrug. Pharmaceutical Research 24:1, 194-200
CrossRef101
Rabih O. Darouiche, Lance Goetz, Teresa Kaldis, Colleen Cerra-Stewart, Atef AlSharif, Michael Priebe. (2006) Impact of StatLock securing device on symptomatic catheter-related urinary tract infection: A prospective, randomized, multicenter clinical trial. American Journal of Infection Control 34:9, 555-560
CrossRef102
Patricia J. Posa, Denise Harrison, Kathleen M. Vollman. (2006) Elimination of Central Line–associated Bloodstream Infections. AACN Advanced Critical Care 17:4, 446-454
CrossRef103
D. G. Maki, D. M. Kluger, C. J. Crnich. (2006) The Risk of Bloodstream Infection in Adults With Different Intravascular Devices: A Systematic Review of 200 Published Prospective Studies. Mayo Clinic Proceedings 81:9, 1159-1171
CrossRef104
Charmaine E. Lok. (2006) Avoiding Trouble Down the Line: The Management and Prevention of Hemodialysis Catheter-Related Infections. Advances in Chronic Kidney Disease 13:3, 225-244
CrossRef105
David K. Warren, Sara E. Cosgrove, Daniel J. Diekema, Gianna Zuccotti, Michael W. Climo, Maureen K. Bolon, Jerome I. Tokars, Gary A. Noskin, Edward S. Wong, Kent A. Sepkowitz, Loreen A. Herwaldt, Trish M. Perl, Steven L. Solomon, Victoria J. Fraser, . (2006) A Multicenter Intervention to Prevent Catheter‐Associated Bloodstream Infections • . Infection Control and Hospital Epidemiology 27:7, 662-669
CrossRef106
F. Hammarskjold, G. Wallen, B. E. Malmvall. (2006) Central venous catheter infections at a county hospital in Sweden: a prospective analysis of colonization, incidence of infection and risk factors. Acta Anaesthesiologica Scandinavica 50:4, 451-460
CrossRef107
R. O. Darouiche, M. D. Mansouri, E. M. Kojic. (2006) Antifungal activity of antimicrobial-impregnated devices. Clinical Microbiology and Infection 12:4, 397-399
CrossRef108
Marin H. Kollef. (2006) The Intensive Care Unit as a Research Laboratory: Developing Strategies to Prevent Antimicrobial Resistance. Surgical Infections 7:2, 85-99
CrossRef109
Peng Wu, David W. Grainger. (2006) Drug/device combinations for local drug therapies and infection prophylaxis. Biomaterials 27:11, 2450-2467
CrossRef110
G. Donelli, I. Francolini, V. Ruggeri, E. Guaglianone, L. D'Ilario, A. Piozzi. (2006) Pore formers promoted release of an antifungal drug from functionalized polyurethanes to inhibit Candida colonization. Journal of Applied Microbiology 100:3, 615-622
CrossRef111
Ronald J. Lubelchek, Robert A. Weinstein. (2006) Strategies for preventing catheter-related bloodstream infections: The role of new technologies*. Critical Care Medicine 34:3, 905-907
CrossRef112
David Fraenkel, Claire Rickard, Peter Thomas, Joan Faoagali, Narelle George, Robert Ware. (2006) A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters*. Critical Care Medicine 34:3, 668-675
CrossRef113
Bernard Messing, Francisca Joly. (2006) Guidelines for Management of Home Parenteral Support in Adult Chronic Intestinal Failure Patients. Gastroenterology 130:2, S43-S51
CrossRef114
S. Osma, Ş.F. Kahveci, F.N. Kaya, H. Akalın, C. Özakın, E. Yılmaz, O. Kutlay. (2006) Efficacy of antiseptic-impregnated catheters on catheter colonization and catheter-related bloodstream infections in patients in an intensive care unit. Journal of Hospital Infection 62:2, 156-162
CrossRef115
M.A. Hernández Hernández, C. Álvarez Antoñan, M.A. Pérez-Ceballos. (2006) Complicaciones de la canalización de una vía venosa central. Revista Clínica Española 206:1, 50-53
CrossRef116
Rachel C. Orscheln, Henry R. Shinefield, Joseph W. St. Geme. 2006. Staphylococcal Infections. , 513-543.
CrossRef117
2006. Rifamycins. , 3040-3051.
CrossRef118
Thomas S. Monahan, Matthew D. Phaneuf, Mauricio A. Contreras, Nicholas D. Andersen, Alexandra Popescu-Vladimir, Martin J. Bide, Donald J. Dempsey, Richard N. Mitchell, Allen D. Hamdan, Frank W. LoGerfo. (2006) In Vivo Testing of an Infection-Resistant Annuloplasty Ring. Journal of Surgical Research 130:1, 140-145
CrossRef119
Martin W. D??nser, Andreas J. Mayr, Guido Hinterberger, Cornelia Lass Fl??rl, Hanno Ulmer, Stefan Schmid, Barbara Friesenecker, Ingo Lorenz, Walter R. Hasibeder. (2005) Central Venous Catheter Colonization in Critically Ill Patients: A Prospective, Randomized, Controlled Study Comparing Standard with Two Antiseptic-Impregnated Catheters. Anesthesia & Analgesia1778-1784
CrossRef120
Andrew F. Shorr, William L. Jackson. (2005) Deep vein thrombosis in the intensive care unit: underappreciated, understudied, and undertreated. Journal of Critical Care 20:4, 301-303
CrossRef121
Cassandra D. Salgado, Naomi O??Grady, Barry M. Farr. (2005) Prevention and control of antimicrobial-resistant infections in intensive care patients*. Critical Care Medicine 33:10, 2373-2382
CrossRef122
F. Heidenau, W. Mittelmeier, R. Detsch, M. Haenle, F. Stenzel, G. Ziegler, H. Gollwitzer. (2005) A novel antibacterial titania coating: Metal ion toxicity and in vitro surface colonization. Journal of Materials Science: Materials in Medicine 16:10, 883-888
CrossRef123
E.W. Moretti, C.L. Ofstead, R.M. Kristy, H.P. Wetzler. (2005) Impact of central venous catheter type and methods on catheter-related colonization and bacteraemia. Journal of Hospital Infection 61:2, 139-145
CrossRef124
C. J. Crnich, D. G. Maki. (2005) Are Antimicrobial-Impregnated Catheters Effective? When Does Repetition Reach the Point of Exhaustion?. Clinical Infectious Diseases 41:5, 681-685
CrossRef125
Susan E. Coffin, Theoklis E. Zaoutis. (2005) Infection Control, Hospital Epidemiology, and Patient Safety. Infectious Disease Clinics of North America 19:3, 647-665
CrossRef126
Rabih O. Darouiche, David H. Berger, Nancy Khardori, Claudia S. Robertson, Matthew J. Wall, Michael H. Metzler, Seema Shah, Mohammad D. Mansouri, Colleen Cerra-Stewart, James Versalovic, Michael J. Reardon, Issam I. Raad. (2005) Comparison of Antimicrobial Impregnation With Tunneling of Long-term Central Venous Catheters. Annals of Surgery 242:2, 193-200
CrossRef127
Itzhak Levy, Jacob Katz, Ester Solter, Zmira Samra, Bernardo Vidne, Einat Birk, Shai Ashkenazi, Ovadia Dagan. (2005) Chlorhexidine-Impregnated Dressing for Prevention of Colonization of Central Venous Catheters in Infants and Children. The Pediatric Infectious Disease Journal 24:8, 676-679
CrossRef128
Marin H. Kollef, Scott T. Micek. (2005) Strategies to prevent antimicrobial resistance in the intensive care unit. Critical Care Medicine 33:8, 1845-1853
CrossRef129
Rafael Ponikvar, Jadranka Buturovic-Ponikvar. (2005) Temporary Hemodialysis Catheters as a Long-term Vascular Access in Chronic Hemodialysis Patients. Therapeutic Apheresis and Dialysis 9:3, 250-253
CrossRef130
A. F. Widmer. (2005) Infektionen und Sepsis durch intravenöse Katheter. Der Internist 46:6, 643-651
CrossRef131
Rafael Ponikvar. (2005) Hemodialysis Catheters. Therapeutic Apheresis and Dialysis 9:3, 218-222
CrossRef132
ANIL K SAXENA, BODH R PANHOTRA. (2005) Prevention of catheter-related bloodstream infections: An appraisal of developments in designing an infection-resistant 'dream dialysis-catheter' (Review Article). Nephrology 10:3, 240-248
CrossRef133
Rogier C. J. de Jonge, Kees H. Polderman, Reinoud J. B. J. Gemke. (2005) Central venous catheter use in the pediatric patient: Mechanical and infectious complications. Pediatric Critical Care Medicine 6:3, 329-339
CrossRef134
Richard A. Mladick. (2005) SIGNIFICANCE OF Staphylococcus epidermidis CAUSING SUBCLINICAL INFECTION. Plastic and Reconstructive Surgery 115:5, 1426-1427
CrossRef135
Andrea M. Kline. (2005) Pediatric Catheter-related Bloodstream Infections. AACN Clinical Issues: Advanced Practice in Acute and Critical Care 16:2, 185-198
CrossRef136
K. Jaeger, S. Zenz, B. J
ttner, H. Ruschulte, E. Kuse, J. Heine, S. Piepenbrock, A. Ganser, M. Karthaus. (2005) Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter. Annals of Hematology 84:4, 258-262
CrossRef137
A. M. Carbonell, B. D. Matthews, D. Dreau, M. Foster, C. E. Austin, K. W. Kercher, R. F. Sing, B. T. Heniford. (2005) The susceptibility of prosthetic biomaterials to infection. Surgical Endoscopy 19:3, 430-435
CrossRef138
Troy Kimsey. 2005. Parenteral Nutrition Access for the Critically Ill. , 219-234.
CrossRef139
Song Yup Han, Soo Han Yoon, Ki Hong Cho, Han Jin Cho, Jeong Ho An, Young Sin Ra. (2005) Biodegradable Polymer Releasing Antibiotic Developed for Drainage Catheter of Cerebrospinal Fluid: In Vitro Results. Journal of Korean Medical Science 20:2, 297
CrossRef140
Hiromasa MITSUHATA. (2005) Clinical Effectiveness of Antimicrobial-Impregnated Central Venous Catheter and Anaphylaxis Induced by the Catheter. THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA 25:7, 637-644
CrossRef141
Christof von Eiff, Bernd Jansen, Wolfgang Kohnen, Karsten Becker. (2005) Infections Associated with Medical Devices. Drugs 65:2, 179-214
CrossRef142
Kedar S. Deshpande, Carlo Hatem, Harry L. Ulrich, Brian P. Currie, Thomas K. Aldrich, Christopher W. Bryan-Brown, Vladimir Kvetan. (2005) The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population*. Critical Care Medicine 33:1, 13-20
CrossRef143
Fabio Paglialonga, Susanna Esposito, Alberto Edefonti, Nicola Principi. (2004) Catheter-related infections in children treated with hemodialysis. Pediatric Nephrology 19:12, 1324-1333
CrossRef144
Jonathan Cohen, Christian Brun-Buisson, Antoni Torres, James Jorgensen. (2004) Diagnosis of infection in sepsis: An evidence-based review. Critical Care Medicine 32:Supplement, S466-S494
CrossRef145
M. Koldehoff, J.L. Zakrzewski.. (2004) Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients. International Journal of Antimicrobial Agents 24:5, 491-495
CrossRef146
Michael Allon. (2004) Dialysis catheter-related bacteremia: Treatment and prophylaxis. American Journal of Kidney Diseases 44:5, 779-791
CrossRef147
Jean-Louis Vincent, Marialuisa Chierego, Marc Struelens, Baudouin Byl. (2004) Infection control in the intensive care unit. Expert Review of Anti-infective Therapy 2:5, 795-805
CrossRef148
Crist
CrossRef149
Philippe Eggimann, Hugo Sax, Didier Pittet. (2004) Catheter-related infections. Microbes and Infection 6:11, 1033-1042
CrossRef150
Robert J Sherertz. (2004) Update on vascular catheter infections. Current Opinion in Infectious Diseases 17:4, 303-307
CrossRef151
Albert G. Crawford, Joseph P. Fuhr, Bhaskar Rao. (2004) Cost–Benefit Analysis of Chlorhexidine Gluconate Dressing in the Prevention of Catheter‐Related Bloodstream Infections • . Infection Control and Hospital Epidemiology 25:8, 668-674
CrossRef152
Simon Desmeules, Bernard Canaud. (2004) Venous Access for Chronic Hemodialysis: "Undesirable Yet Unavoidable". Artificial Organs 28:7, 611-616
CrossRef153
Rolf Bambauer, Reinhard Latza, Silke Bambauer, Eric Tobin. (2004) Large Bore Catheters with Surface Treatments versus Untreated Catheters for Vascular Access in Hemodialysis. Artificial Organs 28:7, 604-610
CrossRef154
Mathias Zürcher, Martin R. Tramèr, Bernhard Walder. (2004) Colonization and Bloodstream Infection with Single- Versus Multi-Lumen Central Venous Catheters: A Quantitative Systematic Review. Anesthesia & Analgesia 99:1, 177-182
CrossRef155
Lorenzo Berra, Lorenzo De Marchi, Zu-Xi Yu, Patrice Laquerriere, Andrea Baccarelli, Theodor Kolobow. (2004) Endotracheal Tubes Coated with Antiseptics Decrease Bacterial Colonization of the Ventilator Circuits, Lungs, and Endotracheal Tube. Anesthesiology 100:6, 1446-1456
CrossRef156
Silvia F Costa, Marisa H Miceli, Elias J Anaissie. (2004) Mucosa or skin as source of coagulase-negative staphylococcal bacteraemia?. The Lancet Infectious Diseases 4:5, 278-286
CrossRef157
C. J. Crnich, D. G. Maki. (2004) Are Antimicrobial-Impregnated Catheters Effective? Don't Throw Out the Baby with the Bathwater. Clinical Infectious Diseases 38:9, 1287-1292
CrossRef158
Jean-Jacques Parienti, Damien du Cheyron, Michel Ramakers, Brigitte Malbruny, Roland Leclercq, Xavier Le Coutour, Pierre Charbonneau. (2004) Alcoholic povidone-iodine to prevent central venous catheter colonization: A randomized unit-crossover study*. Critical Care Medicine 32:3, 708-713
CrossRef159
Scott O. Trerotola. (2004) Catheters: A Necessary Evil?. Journal of Vascular and Interventional Radiology 15:2, P206-P209
CrossRef160
Taka-aki Nakada, Hiroyuki Hirasawa, Shigeto Oda, Hidetoshi Shiga, Kazuya Nakanishi, Ken-Ichi Matsuda, Masataka Nakamura, Masayuki Shima, Masaharu Watanabe. (2004) Catheter-Related Infections in Continuous Hemodiafiltration in Intensive Care Patients. Blood Purification 22:5, 416-422
CrossRef161
Ioannis Chatzinikolaou, Hend Hanna, Linda Graviss, Gassan Chaiban, Cheryl Perego, Rebecca Arbuckle, Richard Champlin, Rabih Darouiche, George Samonis, Issam Raad. (2003) Clinical Experience With Minocycline and Rifampin—Impregnated Central Venous Catheters in Bone Marrow Transplantation Recipients: Efficacy and Low Risk of Developing Staphylococcal Resistance • . Infection Control and Hospital Epidemiology 24:12, 961-963
CrossRef162
James M. O'Brien, Edward Abraham. (2003) New approaches to the treatment of sepsis. Clinics in Chest Medicine 24:4, 521-548
CrossRef163
Juan Alonso‐Echanove, Jonathan R. Edwards, Michael J. Richards, Patrick Brennan, Richard A. Venezia, Janet Keen, Vivian Ashline, Kathy Kirkland, Ellen Chou, Mark Hupert, Abigail V. Veeder, Janice Speas, Judy Kaye, Kailash Sharma, Aliki Martin, V. Dianne Moroz, Robert P. Gaynes. (2003) Effect of Nurse Staffing and Antimicrobial‐Impregnated Central Venous Catheters on the Risk for Bloodstream Infections in Intensive Care Units • . Infection Control and Hospital Epidemiology 24:12, 916-925
CrossRef164
Eric J. Tobin, Rolf Bambauer. (2003) Silver Coating of Dialysis Catheters to Reduce Bacterial Colonization and Infection. Therapeutic Apheresis and Dialysis 7:6, 504-509
CrossRef165
Robert J. Sherertz, William R. Jarvis. (2003) Vascular Catheters Inserted in the Trenches Versus Guideline Documents: Can the Discrepancies Be Resolved? • . Infection Control and Hospital Epidemiology 24:12, 887-889
CrossRef166
Amit Singal, Preeti N. Malani, Larry J. Day, Francis D. Pagani, Nina M. Clark. (2003) Roseomonas Infection Associated With a Left Ventricular Assist Device • . Infection Control and Hospital Epidemiology 24:12, 963-965
CrossRef167
Steven D Miller, Richard J Andrassy. (2003) Complications in pediatric surgical oncology. Journal of the American College of Surgeons 197:5, 832-837
CrossRef168
L Corral, M Nolla-Salas, J Ibañez-Nolla, M.A León, R.M Dı́az, M Cruz Martı́n, R Iglesia, R Catalan. (2003) A prospective, randomized study in critically ill patients using the Oligon Vantex® catheter. Journal of Hospital Infection 55:3, 212-219
CrossRef169
Richard C. Prielipp, Robert J. Sherertz. (2003) Skin: The First Battlefield. Anesthesia & Analgesia933-935
CrossRef170
Ray Y. Hachem, Kenneth C. Wright, Alfonso Zermeno, Gerald P. Bodey, Issam I. Raad. (2003) Evaluation of the silver iontophoretic catheter in an animal model. Biomaterials 24:20, 3619-3622
CrossRef171
Donald L. Miller, Naomi P. O'Grady. (2003) Guidelines for the Prevention of Intravascular Catheter-related Infections: Recommendations Relevant to Interventional Radiology. Journal of Vascular and Interventional Radiology 14:9, S355-S358
CrossRef172
S Harbarth, H Sax, P Gastmeier. (2003) The preventable proportion of nosocomial infections: an overview of published reports. Journal of Hospital Infection 54:4, 258-266
CrossRef173
B. M. Dobbins, J. A. Catton, M. J. Tighe, G. V. Miller, I. G. Martin, M. J. McMahon. (2003) Randomized clinical trials to determine the role of topical glyceryl trinitrate in peripheral intravenous nutrition. British Journal of Surgery 90:7, 804-810
CrossRef174
J CARCILLO. (2003) Pediatric septic shock and multiple organ failure. Critical Care Clinics 19:3, 413-440
CrossRef175
Joseph M. Zabramski, Donald Whiting, Rabih O. Darouiche, Terry G. Horner, Jeffrey Olson, Claudia Robertson, Allan J. Hamilton. (2003) Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. Journal of Neurosurgery 98:4, 725-730
CrossRef176
McGee, David C., Gould, Michael K., . (2003) Preventing Complications of Central Venous Catheterization. New England Journal of Medicine 348:12, 1123-1133
Full Text177
D MILLER, N OGRADY. (2003) Guidelines for the Prevention of Intravascular Catheter-related Infections: Recommendations Relevant to Interventional Radiology. Journal of Vascular and Interventional Radiology 14:2, 133-136
CrossRef178
Marco Ranucci, Giuseppe Isgrò, Pier Paolo Giomarelli, Marco Pavesi, Aldo Luzzani, Iolter Cattabriga, Manuela Carli, Paolo Giomi, Antonio Compostella, Antonio Digito, Valerio Mangani, Vito Silvestri, Enzo Mondelli. (2003) Impact of oligon central venous catheters on catheter colonization and catheter-related bloodstream infection. Critical Care Medicine 31:1, 52-59
CrossRef179
David S. Jones, Shauna McMeel, Colin G. Adair, Sean P. Gorman. (2003) Characterisation and evaluation of novel surfactant bacterial anti-adherent coatings for endotracheal tubes designed for the prevention of ventilator-associated pneumonia. Journal of Pharmacy and Pharmacology 55:1, 43-52
CrossRef180
Naomi P. O’Grady, Julie L. Gerberding, Robert A. Weinstein, Henry Masur. (2003) Patient safety and the science of prevention: The time for implementing the Guidelines for the Prevention of Intravascular Catheter-Related Infections is now. Critical Care Medicine 31:1, 291-292
CrossRef181
David L. Paterson, John D. Rihs, Cheryl Squier, Timothy Gayowski, Asia Sagnimeni, Nina Singh. (2003) Lack of efficacy of mupirocin in the prevention of infections with staphylococcus aureus in liver transplant recipients and candidates1. Transplantation 75:2, 194-198
CrossRef182
Rabih O. Darouiche, David T. Netscher, Mohammad D. Mansouri, Ricardo Meade. (2002) Activity of Antimicrobial-Impregnated Silicone Tissue Expanders. Annals of Plastic Surgery 49:6, 567-571
CrossRef183
Naomi P. O’Grady, Mary Alexander, E. Patchen Dellinger, Julie L. Gerberding, Stephen O. Heard, Dennis G. Maki, Henry Masur, Rita D. McCormick, Leonard A. Mermel, Michele L. Pearson, Issam I. Raad, Adrienne Randolph, Robert Weinstein, . (2002) Guidelines for the Prevention of Intravascular Catheter–Related Infections • . Infection Control and Hospital Epidemiology 23:12, 759-769
CrossRef184
Geoffrey Taylor, Denise Gravel, Lynn Johnston, John Embil, Donna Holton, Shirley Paton, , . (2002) Prospective Surveillance for Primary Bloodstream Infections Occurring in Canadian Hemodialysis Units • . Infection Control and Hospital Epidemiology 23:12, 716-720
CrossRef185
Daniel P. Raymond, Matthew J. Kuehnert, Robert G. Sawyer. (2002) Preventing Antimicrobial-Resistant Bacterial Infections in Surgical Patients. Surgical Infections 3:4, 375-385
CrossRef186
Naomi P. O'Grady, Mary Alexander, E. Patchen Dellinger, Julie L. Gerberding, Stephen O. Heard, Dennis G. Maki, Henry Masur, Rita D. McCormick, Leonard A. Mermel, Michele L. Pearson, Issam I. Raad, Adrienne Randolph, Robert A. Weinstein. (2002) Guidelines for the Prevention of Intravascular Catheter–Related Infections. Clinical Infectious Diseases 35:11, 1281-1307
CrossRef187
Bernhard Walder, Didier Pittet, Martin R. Tramer. (2002) Prevention of Bloodstream Infections With Central Venous Catheters Treated With Anti‐Infective Agents Depends on Catheter Type and Insertion Time: Evidence From a Meta‐Analysis • . Infection Control and Hospital Epidemiology 23:12, 748-756
CrossRef188
ELHANAN NAHUM, ITZHAK LEVY, JACOB KATZ, ZMIRA SAMRA, SHAI ASHKENAZI, JOSEF BEN-ARI, TOMMY SCHONFELD, OVADIA DAGAN. (2002) Efficacy of subcutaneous tunneling for prevention of bacterial colonization of femoral central venous catheters in critically ill children. The Pediatric Infectious Disease Journal 21:11, 1000-1004
CrossRef189
Bart J. A. Rijnders, Eric Van Wijngaerden, Willy E. Peetermans. (2002) Catheter‐Tip Colonization as a Surrogate End Point in Clinical Studies on Catheter‐Related Bloodstream Infection: How Strong Is the Evidence?. Clinical Infectious Diseases 35:9, 1053-1058
CrossRef190
NASIA SAFDAR, DANIEL M. KLUGER, DENNIS G. MAKI. (2002) A Review of Risk Factors for Catheter-Related Bloodstream Infection Caused by Percutaneously Inserted, Noncuffed Central Venous Catheters. Medicine 81:6, 466-479
CrossRef191
Carmen Lorente, Yolanda del Castillo, Jordi Rello. (2002) Prevention of infection in the intensive care unit: current advances and opportunities for the future. Current Opinion in Critical Care 8:5, 461-464
CrossRef192
Rondall K. Lane, Michael A. Matthay. (2002) Central line infections. Current Opinion in Critical Care 8:5, 441-448
CrossRef193
G. Fatkenheuer, O. Cornely, H. Seifert. (2002) Clinical management of catheter-related infections. Clinical Microbiology and Infection 8:9, 545-550
CrossRef194
Naomi P. O'Grady. (2002) Applying the science to the prevention of catheter-related infections. Journal of Critical Care 17:2, 114-121
CrossRef195
Christopher J. Crnich, Dennis G. Maki. (2002) The Promise of Novel Technology for the Prevention of Intravascular Device–Related Bloodstream Infection. II. Long‐Term Devices. Clinical Infectious Diseases 34:10, 1362-1368
CrossRef196
D.J. Stickler. (2002) Susceptibility of antibiotic-resistant Gram-negative bacteria to biocides: a perspective from the study of catheter biofilms. Journal of Applied Microbiology 92:s1, 163S-170S
CrossRef197
Christopher J. Crnich, Dennis G. Maki. (2002) The Promise of Novel Technology for the Prevention of Intravascular Device–Related Bloodstream Infection. I. Pathogenesis and Short‐Term Devices. Clinical Infectious Diseases 34:9, 1232-1242
CrossRef198
P. Eggimann, D. Pittet. (2002) Overview of catheter-related infections with special emphasis on prevention based on educational programs. Clinical Microbiology and Infection 8:5, 295-309
CrossRef199
A. Pascual. (2002) Pathogenesis of catheter-related infections: lessons for new designs. Clinical Microbiology and Infection 8:5, 256-264
CrossRef200
Janneke P. van Grafhorst, Norbert A. Foudraine, Fleur Nooteboom, Wil H. J. Crombach, Nico J. J. Oldenhof, Hans van Doorne. (2002) Unexpected high risk of contamination with staphylococci species attributable to standard preparation of syringes for continuous intravenous drug administration in a simulation model in intensive care units. Critical Care Medicine 30:4, 833-836
CrossRef201
Rabih O. Darouiche, Ricardo Meade, Mohammad D. Mansouri, David T. Netscher. (2002) In Vivo Efficacy of Antimicrobe-Impregnated Saline-Filled Silicone Implants. Plastic and Reconstructive Surgery 109:4, 1352-1357
CrossRef202
Sandro B Rizoli, John C Mashall. (2002) Saturday night fever: finding and controlling the source of sepsis in critical illness. The Lancet Infectious Diseases 2:3, 137-144
CrossRef203
B. Stoiser, J. Kofler, T. Staudinger, A. Georgopoulos, S. Lugauer, J.P. Guggenbichler, H. Burgmann, M. Frass. (2002) Contamination of central venous catheters in immunocompromised patients: a comparison between two different types of central venous catheters. Journal of Hospital Infection 50:3, 202-206
CrossRef204
Shawn J. Pelletier, Robert G. Sawyer. (2002) Catheter-Related Infections. Problems in General Surgery 19:1, 37-44
CrossRef205
Rabih O Darouiche, Mohammad D Mansouri, Issam I Raad. (2002) Efficacy of antimicrobial-impregnated silicone sections from penile implants in preventing device colonization in an animal model. Urology 59:2, 303-307
CrossRef206
Gordon E. Schutze. (2002) ANTIMICROBIAL-IMPREGNATED CENTRAL VENOUS CATHETERS. The Pediatric Infectious Disease Journal 21:1, 63-64
CrossRef207
Craig M. Coopersmith, Terri L. Rebmann, Jeanne E. Zack, Myrna R. Ward, Roslyn M. Corcoran, Marilyn E. Schallom, Carrie S. Sona, Timothy G. Buchman, Walter A. Boyle, Louis B. Polish, Victoria J. Fraser. (2002) Effect of an education program on decreasing catheter-related bloodstream infections in the surgical intensive care unit. Critical Care Medicine 30:1, 59-64
CrossRef208
Elizabeth A. Krzywda, Charles E. Edmiston. (2002) Central Venous Catheter Infections. Journal of Infusion Nursing 25:1, 29-35
CrossRef209
SIGMUND S. SOCRANSKY, ANNE D. HAFFAJEE. (2002) Dental biofilms: difficult therapeutic targets. Periodontology 2000 28:1, 12-55
CrossRef210
Joseph J. Disa, Michael F. Chiaramonte, John A. Girotto, Marc H. Klein, Nelson H. Goldberg. (2001) Advantages of Autologous Fascia versus Synthetic Patch Abdominal Reconstruction in Experimental Animal Defects. Plastic and Reconstructive Surgery 108:7, 2086-2087
CrossRef211
Barry M. Farr. (2001) Preventing Vascular Catheter‐Related Infections: Current Controversies. Clinical Infectious Diseases 33:10, 1733-1738
CrossRef212
EMANUELE NICASTRI, NICOLA PETROSILLO, PIERLUIGI VIALE, GIUSEPPE IPPOLITO. (2001) Catheter-Related Bloodstream Infections in HIV-Infected Patients. Annals of the New York Academy of Sciences 946:1, 274-290
CrossRef213
Nasia Safdar, Christopher J. Crnich, Dennis G. Maki. (2001) Nosocomial infections in the intensive care unit associated with invasive medical devices. Current Infectious Disease Reports 3:6, 487-495
CrossRef214
Lester A. Sampath, David V. Saborio, Iris Yaron, Shanta Modak. (2001) Safety and Efficacy of an Improved Antiseptic Catheter Impregnated Intraluminally With Chlorhexidine. Journal of Infusion Nursing 24:6, 395-403
CrossRef215
Rodney M. Donlan. (2001) Biofilm Formation: A Clinically Relevant Microbiological Process. Clinical Infectious Diseases 33:8, 1387-1392
CrossRef216
Lester A. Sampath, Suhas M. Tambe, Shanta M. Modak. (2001) In Vitro and In Vivo Efficacy of Catheters Impregnated With Antiseptics or Antibiotics: Evaluation of the Risk of Bacterial Resistance to the Antimicrobials in the Catheters • . Infection Control and Hospital Epidemiology 22:10, 640-646
CrossRef217
T.D. Chugh, Z.U. Khan. (2001) Intravascular device-related infections: antimicrobial catheters as a strategy for prevention. Journal of Hospital Infection 49:1, 1-3
CrossRef218
P. Eggimann, D. Pittet. (2001) Nonantibibiotic measures for the prevention of Gram-positive infections. Clinical Microbiology and Infection 7:4, 91-99
CrossRef219
J. Carratala. (2001) Role of antibiotic prophylaxis for the prevention of intravascular catheter-related infection. Clinical Microbiology and Infection 7:4, 83-90
CrossRef220
George M Nassar, Juan Carlos Ayus. (2001) Infectious complications of the hemodialysis access. Kidney International 60:1, 1-13
CrossRef221
UNKNOWN. (2001) Review Article. Annales Françaises d’Anesthésie et de Réanimation 20:6, 520-536
CrossRef222
John L. Brusch. (2001) CARDIAC INFECTIONS IN THE IMMUNOSUPPRESSED PATIENT. Infectious Disease Clinics of North America 15:2, 613-638
CrossRef223
Gil Hardy, Antonio Campos. (2001) Clinical and pharmaceutical management of deficiencies, excesses and infection with nutrition support. Current Opinion in Clinical Nutrition and Metabolic Care 4:3, 197-200
CrossRef224
Alain Attar, Bernard Messing. (2001) Evidence-based prevention of catheter infection during parenteral nutrition. Current Opinion in Clinical Nutrition and Metabolic Care 4:3, 211-218
CrossRef225
S. M. Tambe. (2001) In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices. Journal of Antimicrobial Chemotherapy 47:5, 589-598
CrossRef226
W KAO, B PAVLOVICSURJANCEV. (2001) MANAGEMENT OF ACUTE HEART FAILURE EXACERBATION. Critical Care Clinics 17:2, 321-335
CrossRef227
Inge C. Gyssens. (2001) Quality measures of antimicrobial drug use. International Journal of Antimicrobial Agents 17:1, 9-19
CrossRef228
Jacob Strahilevitz, Izidore S. Lossos, Anthony Verstandig, Talia Sasson, Yitzhak Kori, Shmuel Gillis. (2001) Vascular Access via Peripherally Inserted Central Venous Catheters (PICCs): Experience in 40 Patients with Acute Myeloid Leukemia at a Single Institute. Leukemia & Lymphoma 40:3-4, 365-371
CrossRef229
Elizabeth Cordes Behringer. (2001) The Intensive Care Unit: Activities of the Anesthesiologist as a Perioperative Consultant. ASA Refresher Courses in Anesthesiology 29:1, 31-39
CrossRef230
H. A. Moss, S. E. Tebbs, M. H. Faroqui, T. Herbst, J. L. Isaac, J. Brown, T. S. J. Elliott. (2000) A central venous catheter coated with benzalkonium chloride for the prevention of catheter-related microbial colonization. European Journal of Anaesthesiology 17:11, 680-687
CrossRef231
M Viot. (2000) Intravenous access: related problems in oncology. International Journal of Antimicrobial Agents 16:2, 165-168
CrossRef232
L Correa, D Pittet. (2000) Problems and solutions in hospital-acquired bacteraemia. Journal of Hospital Infection 46:2, 89-95
CrossRef233
Wang-Huei Sheng, Wen-Je Ko, Jann-Tay Wang, Shan-Chwen Chang, Po-Ren Hsueh, Kwen-Tay Luh. (2000) Evaluation of antiseptic-impregnated central venous catheters for prevention of catheter-related infection in intensive care unit patients. Diagnostic Microbiology and Infectious Disease 38:1, 1-5
CrossRef234
Barry M. Farr. (2000) Antimicrobial catheters: Value and safety. Critical Care Medicine 28:9, 3366-3367
CrossRef235
M.A. Rizvi, S.K. Vesely, J.N. George, L. Chandler, D. Duvall, J.W. Smith, R.O. Gilcher. (2000) Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic-uremic syndrome. Transfusion 40:8, 896-901
CrossRef236
K. A. Poelstra, H. C. van der Mei, B. Gottenbos, D. W. Grainger, J. R. van Horn, H. J. Busscher. (2000) Pooled human immunoglobulins reduce adhesion ofPseudomonas aeruginosa in a parallel plate flow chamber. Journal of Biomedical Materials Research 51:2, 224-232
CrossRef237
David J. Stickler. (2000) Biomaterials to prevent nosocomial infections: is silver the gold standard?. Current Opinion in Infectious Diseases 13:4, 389-393
CrossRef238
Paul B. Langevin. (2000) How Should We Handle Epidural Solutions? One View. Regional Anesthesia and Pain Medicine 25:4, 343-346
CrossRef239
César O. Freytes. (2000) Indications and complications of intravenous devices for chemotherapy. Current Opinion in Oncology 12:4, 303-307
CrossRef240
Beatrice Montdargent, Didier Letourneur. (2000) Toward New Biomaterials • . Infection Control and Hospital Epidemiology 21:6, 404-410
CrossRef241
Shawn J Pelletier, Traves D Crabtree, Thomas G Gleason, Timothy L Pruett, Robert G Sawyer. (2000) Bacteremia associated with central venous catheter infection is not an independent predictor of outcomes11No competing interests declared.. Journal of the American College of Surgeons 190:6, 671-680
CrossRef242
Elaine T. Kaye. (2000) TOPICAL ANTIBACTERIAL AGENTS. Infectious Disease Clinics of North America 14:2, 321-339
CrossRef243
Sanjay Saint, David L. Veenstra, Benjamin A. Lipsky. (2000) The Clinical and Economic Consequences of Nosocomial Central Venous Catheter‐Related Infection: Are Antimicrobial Catheters Useful? • . Infection Control and Hospital Epidemiology 21:6, 375-380
CrossRef244
Bernard Canaud, Helene Leray-Moragues, Khaola Kamoun, Valerie Garrigue. (2000) Temporary Vascular Access for Extracorporeal Therapies. Therapeutic Apheresis and Dialysis 4:3, 249-255
CrossRef245
François Desgrandchamps. (2000) Biomaterials in functional reconstruction. Current Opinion in Urology 10:3, 201-206
CrossRef246
Philippe Eggimann, Stephan Harbarth, Marie-Noëlle Constantin, Sylvie Touveneau, Jean-Claude Chevrolet, Didier Pittet. (2000) Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. The Lancet 355:9218, 1864-1868
CrossRef247
D SIMON, G TRENHOLME. (2000) ANTIBIOTIC SELECTION FOR PATIENTS WITH SEPTIC SHOCK. Critical Care Clinics 16:2, 215-231
CrossRef248
DONALD P. GRIFFITH. (2000) Tissue-Bonding Cystostomy: Potential Alternative for Neuropathic Bladder Dysfunction and Potential Model for Other Prostheses. Journal of Endourology 14:1, 85-92
CrossRef249
RABIH O. DAROUICHE. (2000) Infection-Resistant Alloplasts. Journal of Endourology 14:1, 33-37
CrossRef250
Ignacio A Rojas, Jeffrey B Slunt, David W Grainger. (2000) Polyurethane coatings release bioactive antibodies to reduce bacterial adhesion. Journal of Controlled Release 63:1-2, 175-189
CrossRef251
Stephan Harbarth. (2000) Epidemiologic methods for the prevention of nosocomial infections. International Journal of Hygiene and Environmental Health 203:2, 153-157
CrossRef252
J. R. DeBord, J. J. Bauer, D. M. Grischkan, K. A. LeBlanc, R. T. Smoot, G. R. Voeller, L. H. Weiland. (1999) Short-term study on the safety of antimicrobial-agent-impregnated ePTFE patches for hernia repair. Hernia 3:4, 189-193
CrossRef253
Rabih O Darouiche, Joseph A Smith, Hend Hanna, Chirpriya B Dhabuwala, Michelle S Steiner, Richard J Babaian, Timothy B Boone, Peter T Scardino, John I Thornby, Issam I Raad. (1999) Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: a prospective, randomized, multicenter clinical trial. Urology 54:6, 976-981
CrossRef254
T. S. J. Elliott. (1999) Can antimicrobial central venous catheters prevent associated infection?. British Journal of Haematology 107:2, 235-241
CrossRef255
Fran??ois Blot, Christian Brun-Buisson. (1999) Current approaches to the diagnosis and prevention of catheter-related infections. Current Opinion in Critical Care 5:5, 341-349
CrossRef256
peter Kite, Brian M Dobbins, Mark H Wilcox, Mlchael J McMahon. (1999) Rapid diagnosis of central-venous-catheter-related bloodstream infection without catheter removal. The Lancet 354:9189, 1504-1507
CrossRef257
Jan Namyslowski, Nilesh H. Patel. (1999) Central venous access: A new task for interventional radiologists. CardioVascular and Interventional Radiology 22:5, 355-368
CrossRef258
David P. Calfee, Barry M. Farr. (1999) Catheter-related bloodstream infectio. Current Infectious Disease Reports 1:3, 238-244
CrossRef259
Lalita Khaodhiar, Bruce R. Bistrian. (1999) Avoidance and Management of Complications of Total Parenteral Nutrition. Nutrition in Clinical Care 2:4, 239-249
CrossRef260
Isaam Raad. (1999) In Vitro Activity of Rifampin-Minocyclin Coating to Candida albicans. Critical Care Medicine 27:8, 1692-1693
CrossRef261
Ann M. Loeffler. (1999) USES OF RIFAMPIN FOR INFECTIONS OTHER THAN TUBERCULOSIS. The Pediatric Infectious Disease Journal 18:7, 631-632
CrossRef262
(1999) Antimicrobial-Impregnated Central Venous Catheters. New England Journal of Medicine 340:22, 1761-1762
Full Text263
Jordi Rello. (1999) Impact of Nosocomial Infections on Outcome: Myths and Evidence • . Infection Control and Hospital Epidemiology 20:6, 392-394
CrossRef264
W. C. Albrich, M. Angstwurm, L. Bader, R. Gärtner. (1999) Drug resistance in intensive care units. Infection 27:S2, S19-S23
CrossRef265
Wenzel, Richard P., Edmond, Michael B., . (1999) The Evolving Technology of Venous Access. New England Journal of Medicine 340:1, 48-50
Full Text266
I LEITMAN, V SUBRAMANIAN. (1999) Central venous catheters: Can we control the infections?. Current Surgery 56:1-2, 24-29
CrossRef
- Letters
